Match Document Document Title
DE10230692A1 Methods and nucleic acids for the analysis of methylation patterns within the DD3 gene  
The present invention provides methods and sequences for analysis of methylation patterns within the 5 'and promoter regions of the gene DD3 available.
DE10234126A1 A process for the biotransformation of carotenoids  
The invention relates to a method for the biotransformation of carotenoids using enzymes with cytochrome P450 monooxygenase activity; in particular monooxygenases from thermophilic bacteria,...
DE10232774A1 Cosmetic preparations with antibacterial properties  
invention relates to cosmetic preparations which are characterized in that they contain an effective amount of glycyrrhetic acid and derivatives thereof.
DE10232595A1 Light stabilizers  
The invention relates to a preparation having light-protection properties, comprising at least one compound of formula I where R1 and R2 are selected from H and OR11Wherein OR11 is independently...
DE10231659A1 Composition for binding nucleic acid to a solid phase  
The present invention relates to a composition for binding nucleic acids in aqueous solution to a solid phase containing a guanidinium salt, a buffer substance and a detergent, characterized in...
DE10231370A1 Thiophenglycosidderivate new, processes for their preparation, pharmaceutical compositions containing them and their use  
The invention relates to novel Thiophenglycosidderivate of the formula I, wherein the radicals have the meanings time shown, and their physiologically acceptable salts and processes for their...
DE10231297A1 Nucleotide sequences of coryneform bacteria coding for participating in the biosynthesis of L-serine proteins and methods for producing L-serine  
The invention relates to nucleotide sequences of coryneform bacteria coding for participating in the biosynthesis of L-serine proteins, as well as methods for producing L-serine. By deletion of at...
DE10229391A1 Biochip, useful for identifying metastatizing tumors and assessing metastatic potential, carries cDNA copies of genes with metastasis-specific expression and of control genes  
Biochip comprises, arranged on a carrier: (a) cDNA copies (1) of genes, or their fragments, for which expression is altered in metastasis; and (b) as controls, cDNA copies (2) of genes, or their...
DE20315159U1 Kit for diagnostic detection of severe acute respiratory syndrome-associated virus, comprises primers and probes for a real-time reverse transcription polymerase chain reaction  
Kit for detecting the severe acute respiratory syndrome (SARS)-associated virus (human pneumonia-associated coronavirus; HPAC) by real-time reverse transcription-PCR (RT-PCR). Kit for detecting...
DE19705664B4 A process for producing 1,1-GPM-enriched phase with more than 75 wt .-% solid phase content to 99 wt .-% solid phase content of 1,1-GPM and 1,6-GPS-enriched phase with more than 80 wt .-% solid phase content to about 99 wt .-% solid phase content of 1,6 GPS  
A process for producing 1,1-GPM-enriched phases with more than 75 wt .-% solid phase content to about 99 wt .-% solid phase content of 1,1-GPM and 1,6-GPS-enriched phase with more than 80 percent....
DE10232139A1 With nucleic acids and nucleic acid derivatives of coated metallic object, process for its preparation and its use  
A metallic article having a metal oxide layer and an anodic polarization stable enshrined therein nucleic acid coating. The coating may be adjusted by hybridization of complementary strands and to...
DE10228857A1 Tetraether lipids with small head groups, their preparation and use  
Tetraether are bipolar Amiphile, originally isolated from natural bacteria. They are used for spherical vesicles, pharmaceutical formulations, among others, but are derived from thermophilic...
DE20121978U1 Novel chemically modified genomic DNA sequences, useful in the characterization, classification, differentiation, grading, staging, treatment and/or diagnosis of astrocytomas or predisposition to astrocytomas  
A nucleic acid (I) comprising a sequence of at least 18 bases in length of a segment of chemically pretreated genomic DNA which has any one of the sequences of (S1)-(S120) or its complement, is...
DE20121975U1 Oligonucleotide for diagnosing and treating tumors and cancer especially gliomas, astrocytomas and oligodendromas, comprises chemically modified genomic sequences of genes associated with tumors and cancers  
A nucleic acid (I) comprising a sequence of at least 18 bases of a segment of chemically pretreated genomic DNA (II) according to one of the sequences (S1) selected from 120 sequences, and its...
DE20121964U1 New nucleic acid, useful for diagnosis and therapy of metabolic disease, solid tumor and cancers, comprises segment of chemically modified genomic sequences of genes associated with metabolism  
A nucleic acid (I) comprising a sequence at least 18 bases of a segment of the chemically pretreated DNA of genes associated with metabolism such as DUSP2 (NM 004418), EPHX2 (NM 001979), QDPR (NM...
DE20121960U1 New nucleic acid derived from chemically treated metastasis genes, useful for diagnosis of cancers by analysis of cytosine methylation, also for treatment  
Nucleic acid (I) comprising at least 18 bases from a segment of the chemically pretreated DNA (A) of genes associated with metastasis, i.e. any of 198 sequences referred to but not reproduced or...
DE10229978A1 Preparation of conjugated polyunsaturated fatty acids, useful in nutrition, cosmetics and pharmaceuticals, comprises expressing specific isomerases in eukaryotic, particularly plant, cells  
Preparation of conjugated polyunsaturated fatty acids (I), having at least two double bonds, in transgenic eukaryotic organisms comprises expressing a specific nucleic acid (II) in an organism...
DE10228785B4 Detection of toxic algae  
oligonucleotide characterized in that one of the sequences SEQ ID No.1 to 19 exhibits.
DE10228785A1 Detection of toxic algae  
The invention relates to sequence-specific capture probes for the detection of toxic algae by selective hybridization of a complementary, to be detected alga clearly characterizing the nucleic...
DE10227432A1 A process for the separation of carbohydrate carboxylic acids  
The present invention relates to a method for the separation of carboxylic acids from their carbohydrate mixture by an at least single-stage reactive extraction with an extractant system...
DE10227814A1 A process for the elimination of labile funtionellen groups of chemical compounds  
The present invention provides a method for cleavage of labile functional groups from molecules by the action of electromagnetic radiation is available, wherein the molecules are brought together...
DE10226203B4 Condensed palatinose, processes for their preparation and their use  
process for producing condensed palatinose from palatinose by Melt, Palatinose a solution of a catalytically active acidic Substance added to water, the water in the obtained mixture is present in...
DE10226203A1 Condensed palatinose and processes for their preparation  
The invention relates to a novel palatinose condensation product obtained by condensation of the disaccharide palatinose in a melt of palatinose, water and an organic acid.
DE20121979U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121977U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121974U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121973U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121972U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121971U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121970U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121969U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121965U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10325815A1 New variant DNA sequence, useful for diagnosis of e.g. defecation disorders and thyroid carcinoma, is derived from the promoter region of the human RET proto-oncogene  
DNA sequence (I) that comprises the -1 to -30 region of the 5'-untranslated region (UTR) of the human RET proto-oncogene and includes the variations A at -1 to T, C or G and/or G at -5 to T, C or...
DE10226367A1 Gangliosides with modified acyl function  
A ganglioside mixture is prepared, the gangliosides of the following general formula I: DOLLAR A (sugar) -OCH¶2¶-CH (-NH-CO-R · 1 ·) -CH (OH) -CH = CH-R · 2 · Wherein DOLLAR A (sugar) represents a...
DE10225705A1 Banding of banknotes  
The invention relates to a banding machine for banknotes and a banknote processing apparatus with such a banding machine. A particularly safe and fast banding is possible if a guide for forming a...
DE10225628A1 CDG therapy with mannose  
Mannose 1-phosphate derivatives and pharmaceutical or dietetic agents containing them for the treatment of glycosylation disorders and in particular for the treatment of CDG-Ia are provided. These...
DE20121968U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121967U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121963U1 Nucleic acids for diagnosis of diseases associated with developmental genes  
Nucleic acid of genes that are associated with the development, comprising an at least 18 base long sequence segment of the chemically pretreated DNA of one of the sequences selected from the...
DE20121961U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10224624A1 Metabolites and prodrugs of 1-dimethylamino-3- (3-methoxyphenyl) -2-methylpentan-3-ol  
The invention relates to the use of 1-phenyl-3-dimethylaminopropanverbindungen for the manufacture of a medicament for the treatment of increased Urndrang or urinary incontinence and corresponding...
DE10223057A1 Process for the production of polynucleotide molecules  
The invention relates to methods for producing polynucleotide molecules with altered properties, wherein at least one cycle comprising the following steps is performed: DOLLAR A (a) providing a...
DE10222632A1 Microsatellite markers for genetic analysis and for the differentiation of roses  
Microsatellites from plants of the genus Rosa, including the isolated microsatellites, primers from flanking regions of the microsatellites, a process for the preparation of the microsatellites...
DE10221004A1 Detection of oligonucleotide hybridization comprises electrochemically detecting reduction and/or oxidation of a redox-active species  
Detection of oligonucleotide hybridization comprises binding uncharged oligonucleotide molecules to a surface, contacting the surface with a solution of a redox-active species, contacting the...
DE10220799A1 Process for the preparation of C13-alcohol mixtures  
The present invention relates to a process for the preparation of a C¶13¶ alcohol mixture, which is particularly suitable as a precursor for the preparation of compounds having surface-active...
DE10222858A1 Process for the fermentative production of sulfur-containing fine chemicals  
The invention relates to processes for the fermentative production of sulfur-containing fine chemicals, in particular L-methionine, using bacteria in which a coding for an S-adenosylmethionine...
DE10222133A1 Method for nucleic acid extraction and nucleic acid purification  
The present invention relates to the use of multivalent cations and complexing agents for nucleic acid extraction and nucleic acid purification with silica-based support materials, in particular...
DE10221836A1 Attenuation of metapneumovirus  
The present invention relates to a vaccine against members of the genus metapneumovirus or RSV or a virus having significant genetic homology in the F protein to members of the genus...
DE10222494A1 Parallel recovery of RNA and protein from tissue, useful e.g. for diagnosis of tumors, by treating sample with RNAlater solution, homogenizing and separating epithelial cells  
Parallel recovery of RNA and protein comprising first treating a resected tissue sample with a preparation solution containing RNAlater (RTM) at 40-100 g/100 ml, mechanically disintegrating the...
DE10221091A1 SECM for the detection of nucleic acid oligomer hybridization events  
Described is a method of detecting nucleic acid oligomer hybridization events, comprising the steps of providing a modified surface, wherein the modification is the attachment of at least one type...